7. Staging & Grading

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/28

encourage image

There's no tags or description

Looks like no tags are added yet.

29 Terms

1
New cards

workup

series of diagnostic exams performed once tumour is detected

  • goal: to determine general health status of patient + info about tumour

    • informs oncologist on most appropriate treatment

  • specifics depend on cancer type suspected + symptoms experienced by patient

    • test based on tumour characteristics

    • early stage tumours require different tests than late stage, eg. bone scan

  • PET often used to determine

    • site of primary disease

    • areas of secondary disease not detectable by other imaging modalities

    • recurrence post-treatment


2
New cards

tumour info

  • type

  • location

  • size

  • degree tumour has invaded normal tissue

  • amount of cell differentiation

  • presence/absence of spread to distant sites

  • lymph node involvement

  • amenability to specific treatment regimens


3
New cards

tumour stage

defines tumour size + extension at time of diagnosis

  • many common tumour sites have own unique systems

  • purpose

    • helps determine best treatment

    • helps predict prognosis

    • provides means for continued research


4
New cards

universal staging system

  • aids clinician in planning of treatment for each patient

  • assists in evaluation of treatment modalities

  • facilitates exchange of info b/w treatment centres worldwide

  • evaluates outcome of treatment, ie. survival

  • estimates prognosis or outcome by stage + treatment

  • includes

    • TNM staging


5
New cards

TNM staging

  • T → T0-T4, Tx

    • size/extent of invasion of primary tumour

  • N → N0-N4, Nx

    • status of lymph nodes → positive or negative

    • extent of lymph node involvement

    • N1-N3 most commonly seen

  • M → M0-M1, Mx

    • presence + extent of metastasis

  • may have subcategories

    • c = clinical

    • p = pathologic


6
New cards

T

size/extent of primary tumour

  • T0

    • no primary tumour

      • eg. patient w/ elevated PSA can have prostate cancer but hasn't developed a mass yet

  • T1

    • small and/or confined to small area

  • T4

    • extremely large and/or extends to other tissues

  • Tx

    • inability to obtain info to make determination


7
New cards

N

status of lymph nodes (positive/negative) + extent of lymph node involvement

  • N0

    • no lymph node involvement

      • good prognostic factor

  • N1

    • positive nodes close to site of primary tumour → local, regional

  • N4

    • positive nodes at more distant sites

  • Nx

    • nodal status was not assessed


8
New cards

M

presence + extent of metastasis

  • M0

    • no evidence of metastasis found

  • M1

    • disease present away from primary tumour

  • Mx

    • absence/presence of metastatic disease not assessed


9
New cards

R (residual disease status)

absence or presence of residual tumour after treatment

  • Rx

    • presence of residual tumour cannot be assessed

  • R0

    • no residual tumour

  • R1

    • microscopic tumour

  • R2

    • macroscopic residual tumour


10
New cards

clinical staging

subcategory of TNM staging - based on physical exam + imaging

  • eg. T1cN0M0


11
New cards

pathologic staging

subcategory of TNM staging - clinical staging w/ additional info from surgical removal of all or part of tumour, biopsy or removal of lymph node

  • eg. T2pN0M0

  • common to see in breast patient after node biopsy

  • offers most accurate info about tumour + extent of disease spread

    • non-invasive approaches can stage tumours but leave lymph node status + microscopic spread unknown

      • amount of tumour left behind post-surgery important for treatment + prognostic info

  • helps determine if targeted therapies can be used


12
New cards

post-therapy staging

determined after 1st course of treatment to see how treatment has impacted cancer

  • eg. post chemotherapy, hormone therapy, radiation therapy

  • could lead to downstaging


13
New cards

downstaging

preoperative treatment to shrink tumour to make it more surgically accessible

  • often determined after post-therapy staging

  • eg. short course rectum RT

    • T2 ot T3 → shrink down to T1 to make it easier to remove

  • NOTE: does not change original assigned stage

    • eg. initial staging is T3 → stays T3 after shrinking


14
New cards

restaging

performed in cases of cancer recurrence after treatment

15
New cards

grade

based on differentiation level of tumour cells → info about its aggressiveness

  • determined by examining cells under microscope → histology

  • in some cancers = most important prognostic indicator

    • endometrium

    • primary CNS

    • prostate

    • sarcoma

    • breast


<p>based on differentiation level of tumour cells → info about its aggressiveness</p><ul><li><p>determined by examining cells under microscope → histology </p></li><li><p>in some cancers = most important prognostic indicator </p><ul><li><p>endometrium</p></li><li><p><strong>primary CNS</strong></p></li><li><p><strong>prostate</strong> </p></li><li><p>sarcoma </p></li><li><p>breast </p></li></ul></li></ul><p></p>
16
New cards

prognostic factors

  • stage + grade

  • patient age + health before diagnosis

  • patient response to treatment

  • statistics collected over many years about people w/ same type of cancer

  • several types of statistics used to estimate prognosis


17
New cards

prognosis

affected by

  • cancer type + location in body

  • stage of cancer

    • size of tumour

    • presence of spread

  • grade

    • how abnormal cancer cells look under microscope

    • provides clues about how quickly cancer is likely to grow + spread


18
New cards

cancer-specific survival

aka. disease-specific survival

  • % of patients w/ specific type + stage of cancer who have not died from their cancer during certain period of time after diagnosis

  • period of time may be 1/2/5 years, etc.

    • 5 years most often used


19
New cards

relative survival

% of cancer patients who have survived for certain period of time after diagnosis compared to people who do not have cancer

  • how long you survive compared to rest of population

  • estimates cancer-specific survival that does not use info about cause of death


20
New cards

overall survival

% of people w/ specific type + stage of cancer who have not died from any cause during certain period of time after diagnosis

21
New cards

disease-free survival

% of patients who have no signs of cancer during certain period of time after treatment

  • ie. recurrence-free or progression-free survival

  • important for high disease recurrence


22
New cards

breast staging

  • clinical staging (cTNM) → physical exam + imaging studies

  • pathologic staging (pTNM) → detailed pathologic exam of primary tumour + regional lymph nodes

stage

  • 1A = small primary + no lymph node involvement

  • 1B = small primary + lymph node involvement

  • IV = metastatic, any T + any N


TNM → T

  • T1 = <2cm

  • T2 = 2-5cm

  • T3 = >5cm

  • T4 = of any size w/ direct extension to chest wall/skin

    • extension = advanced disease

  • T4d = inflammatory breast cancer

    • specific type of breast cancer involving skin


<ul><li><p>clinical staging (cTNM) → physical exam + imaging studies</p></li><li><p>pathologic staging (pTNM) → detailed pathologic exam of primary tumour + regional lymph nodes </p></li></ul><p><u>stage</u></p><ul><li><p>1A = small primary + no lymph node involvement</p></li><li><p>1B = small primary + lymph node involvement </p></li><li><p>IV = metastatic, any T + any N</p></li></ul><p></p><p><u>TNM → T</u></p><ul><li><p>T1 = &lt;2cm</p></li><li><p>T2 = 2-5cm</p></li><li><p>T3 = &gt;5cm</p></li><li><p>T4 = of <em>any</em> size w/ direct extension to chest wall/skin </p><ul><li><p>extension = advanced disease</p></li></ul></li><li><p> T4d = inflammatory breast cancer </p><ul><li><p>specific type of breast cancer involving skin </p></li></ul></li></ul><p></p>
23
New cards

prostate staging

majority = adenocarcinomas

  • staging incorporates Gleason score = grade looking at cell differentiation → strong correlation to prognosis

    • low score = slowly growing + non-invasive

    • high score = more invasive/metastatic

  • have areas w/ different levels of differentiation

    • pathologist evaluates predominant + less frequent level of differentiation → assign grade

    • if tumour is all same grade, value repeats

      • eg. 3+3=6


Gleason score

  • 2 grades from 1-10 added = Gleason score

    • 1st number = grade most common in tumour

      • eg. 3+4=7 → most of tumour = grade 3 + less = grade 4

        • written as

          • Gleason 7/10

          • Gleason 7 (3+4)

          • combined Gleason grade of 7

TNM staging

  • T1 = not palpable or visible by imaging

  • T2 = confined within prostate

  • T3 = extends through prostatic capsule → into seminal vesicle

  • T4 = invades adjacent structures beyond seminal vesicle

  • M1 = distant metastasis = determines type of treatment → different sites respond to different treatments

    • M1a = non-regional lymph nodes

    • M1b = bone

    • M1c = other sites


<p>majority = adenocarcinomas</p><ul><li><p>staging incorporates <strong>Gleason score</strong> = grade looking at cell differentiation → strong correlation to prognosis</p><ul><li><p>low score = slowly growing + non-invasive</p></li><li><p>high score = more invasive/metastatic</p></li></ul></li><li><p>have areas w/ different levels of differentiation</p><ul><li><p>pathologist evaluates predominant + less frequent level of differentiation → assign grade</p></li><li><p>if tumour is all same grade, value repeats</p><ul><li><p>eg. 3+3=6</p></li></ul></li></ul></li></ul><p></p><p><u>Gleason score</u></p><ul><li><p>2 grades from 1-10 added = Gleason score</p><ul><li><p>1st number = grade most common in tumour</p><ul><li><p>eg. 3+4=7 → most of tumour = grade 3 + less = grade 4</p><ul><li><p>written as</p><ul><li><p>Gleason 7/10</p></li><li><p>Gleason 7 (3+4)</p></li><li><p>combined Gleason grade of 7</p></li></ul></li></ul></li></ul></li></ul></li></ul><p><u>TNM staging</u></p><ul><li><p>T1 = not palpable or visible by imaging </p></li><li><p>T2 = confined within prostate </p></li><li><p>T3 = extends through prostatic capsule → into seminal vesicle </p></li><li><p>T4 = invades adjacent structures beyond seminal vesicle </p></li><li><p>M1 = distant metastasis = determines type of treatment → different sites respond to different treatments </p><ul><li><p>M1a = non-regional lymph nodes</p></li><li><p>M1b = bone</p></li><li><p>M1c = other sites</p></li></ul></li></ul><p></p>
24
New cards

respiratory staging

based on 4 factors

  1. location of primary

  2. tumour size

  3. lymph node involvement

  4. presence/absence of distant metastasis


2 predominant categories of lung cancer

  • NSCLC - non-small cell lung cancer

  • SCLC - small cell lung cancer → more aggressive + natural history highly suggestive of spread

    • further stages as

      • limited stage = only on 1 side of chest + can be treated w/ definite radiation therapy (stage 1/2)

      • extensive stage = cancer spread widely throughout lung/to other body parts

TNM staging

  • T1a = ≤2cm

  • T1b = >2-3cm

  • T2a = >3-5cm

  • T2b = >5-7cm

  • T3 = >7cm, invasion + same lobe nodules

  • T4 = extension + ipsilateral lung

  • M1a = pleural effusion + contralateral lung

  • M1b = distant


<p>based on 4 factors</p><ol><li><p>location of primary</p></li><li><p>tumour size</p></li><li><p>lymph node involvement</p></li><li><p>presence/absence of distant metastasis</p></li></ol><p></p><p>2 predominant categories of lung cancer</p><ul><li><p><strong>NSCLC</strong> - non-small cell lung cancer</p></li><li><p><strong>SCLC</strong> - small cell lung cancer → more aggressive + natural history highly suggestive of spread</p><ul><li><p>further stages as</p><ul><li><p><strong>limited</strong> stage = only on 1 side of chest + can be treated w/ definite radiation therapy (stage 1/2)</p></li><li><p><strong>extensive</strong> stage = cancer spread widely throughout lung/to other body parts</p></li></ul></li></ul></li></ul><p><u>TNM staging</u></p><ul><li><p>T1a = ≤2cm</p></li><li><p>T1b = &gt;2-3cm</p></li><li><p>T2a = &gt;3-5cm</p></li><li><p>T2b = &gt;5-7cm</p></li><li><p>T3 = &gt;7cm, invasion + same lobe nodules </p></li><li><p>T4 = extension + ipsilateral lung</p></li><li><p>M1a = pleural effusion + contralateral lung </p></li><li><p>M1b = distant</p></li></ul><p></p>
25
New cards

CNS staging

no universal staging system in use

  • GTM = Grade, Tumour, Metastasis

    • grade has prognostic significance - G1 → G4


histopathological grading

  • GX = grade cannot be assessed

  • G1 = well differentiated

  • …

  • G4 = undifferentiated

supratentorial

  • T1 = one side ≤ 5cm

  • T2 = one side > 5cm

  • T3 = invades/encroaches ventricular system

  • T4 = opposite side, invades infratentorial

infratentorial

  • T1 = one side ≤ 3cm

  • T2 = one side > 3cm

  • T3 = invades/encroaches ventricular system

  • T4 = opposite side, invades supratentorial


<p>no universal staging system in use </p><ul><li><p>GTM = Grade, Tumour, Metastasis </p><ul><li><p>grade has prognostic significance - G1 → G4</p></li></ul></li></ul><p></p><p><u>histopathological grading</u></p><ul><li><p>GX = grade cannot be assessed </p></li><li><p>G1 = well differentiated </p></li><li><p>…</p></li><li><p>G4 = undifferentiated </p></li></ul><p><strong><u>supra</u></strong><u>tentorial</u></p><ul><li><p>T1 = one side ≤ 5cm</p></li><li><p>T2 = one side &gt; 5cm</p></li><li><p>T3 = invades/encroaches ventricular system</p></li><li><p>T4 = opposite side, invades infratentorial </p></li></ul><p><strong><u>infra</u></strong><u>tentorial</u></p><ul><li><p>T1 = one side ≤ 3cm</p></li><li><p>T2 = one side &gt; 3cm</p></li><li><p>T3 = invades/encroaches ventricular system</p></li><li><p>T4 = opposite side, invades supratentorial </p></li></ul><p></p>
26
New cards

GI staging

TNM staging

  • Tis = carcinoma in situ → intraepithelial/invasion of lamina propria

  • T1 = invades submucosa

  • T2 = invades muscularis propria

  • T3 = invades through muscularis propria into subserosa OR non-peritonealized pericolic/perirectal tissues

  • T4 = directly invades other organs/structures +/ perforates visceral peritoneum

    • T4a = perforates visceral peritoneum

    • T4b = directly invades/adheres to other organs/structures


<p><u>TNM staging</u></p><ul><li><p>Tis = carcinoma <em>in situ</em> → intraepithelial/invasion of lamina propria</p></li><li><p>T1 = invades submucosa </p></li><li><p>T2 = invades muscularis propria</p></li><li><p>T3 = invades through muscularis propria into subserosa OR non-peritonealized pericolic/perirectal tissues</p></li><li><p>T4 = directly invades other organs/structures +/ perforates visceral peritoneum</p><ul><li><p>T4a = perforates visceral peritoneum</p></li><li><p>T4b = directly invades/adheres to other organs/structures</p></li></ul></li></ul><p></p>
27
New cards

esophagus staging

  • tumour w/ epicentre within 5cm of esophagogastric junction + extends into esophagus → classified + staged using esophageal scheme

  • tumour w/ epicentre in stomach ≥5cm from esophagogastric junction w/o extension in esophagus→ classified + staged w/ gastric carcinoma scheme


<ul><li><p>tumour w/ epicentre within 5cm of esophagogastric junction + extends into esophagus → classified + staged using <em>esophageal scheme</em></p></li><li><p>tumour w/ epicentre in stomach ≥5cm from esophagogastric junction w/o extension in esophagus→ classified + staged w/ <em>gastric carcinoma scheme</em></p></li></ul><p></p>
28
New cards

gyne staging

uses International Federation of Gynecology and Obstetrics (FIGO) + TNM staging system

  • major difference = FIGO includes stage 0

  • for cervix → stage most important prognostic indicator


<p>uses International Federation of Gynecology and Obstetrics (FIGO) + TNM staging system</p><ul><li><p>major difference = FIGO includes stage 0</p></li><li><p>for cervix → stage most important prognostic indicator </p></li></ul><p></p>
29
New cards

head and neck staging

staging criteria site specific

<p>staging criteria site specific </p>